Mercer Global Advisors
SMMT icon

Mercer Global Advisors’s Summit Therapeutics SMMT Stock Holding History

Mercer Global Advisors’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-36,452
Closed -$776K – 2734
2025
Q2 		$776K Sell
36,452
-943
-3% -$21.5K ﹤0.01% 1336
2025
Q1 		$721K Sell
37,395
-7,283
-16% -$146K ﹤0.01% 1291
2024
Q4 		$797K Sell
44,678
-131
-0.3% -$2.54K ﹤0.01% 1211
2024
Q3 		$901K Sell
44,809
-2,442
-5% -$34.2K ﹤0.01% 1058
2024
Q2 		$369K Sell
47,251
-1,951
-4% -$10.5K ﹤0.01% 1475
2024
Q1 		$204K Buy
49,202
+902
+2% +$3.59K ﹤0.01% 1776
2023
Q4 		$126K Hold
48,300
– – ﹤0.01% 1892
2023
Q3 		$90K Hold
48,300
– – ﹤0.01% 1861
2023
Q2 		$121K Buy
48,300
+5,200
+12% +$9.49K ﹤0.01% 1809
2023
Q1 		$75K Hold
43,100
– – ﹤0.01% 1845
2022
Q4 		$183K Buy
43,100
+800
+2% +$1.46K ﹤0.01% 1729
2022
Q3 		$50K Buy
42,300
+2,100
+5% +$2.38K ﹤0.01% 1769
2022
Q2 		$40K Buy
40,200
+15,300
+61% +$21.4K ﹤0.01% 1777
2022
Q1 		$61K Buy
24,900
+2,950
+13% +$7.44K ﹤0.01% 1829
2021
Q4 		$59K Buy
21,950
+4,000
+22% +$19.2K ﹤0.01% 1746
2021
Q3 		$90K Hold
17,950
– – ﹤0.01% 1693
2021
Q2 		$134K Buy
17,950
+1,000
+6% +$6.56K ﹤0.01% 1604
2021
Q1 		$99K Buy
+16,950
New +$109K ﹤0.01% 1553

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
ACL
APEIRON Capital Ltd Hong Kong $107M AUM 9.59% 1-Year Est. Return

Mercer Global Advisors's SMMT Position: Q3 2025 in Review

Mercer Global Advisors sold out of Summit Therapeutics (SMMT) in Q3 2025, closing a stake of 36,452 shares — an estimated $776K sold.

Mercer Global Advisors first reported a position in SMMT in Q1 2021 and held it in 18 quarters. The position peaked at $901K in Q3 2024. 232 funds tracked by Wall St. Rank hold SMMT as of Q3 2025.

  • Mercer Global Advisors reported no remaining Summit Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Mercer Global Advisors sold 36,452 Summit Therapeutics shares in Q3 2025, an estimated $776K.
  • Mercer Global Advisors first reported a position in Summit Therapeutics in Q1 2021 and held it in 18 quarters.
  • Mercer Global Advisors's Summit Therapeutics position peaked at $901K in Q3 2024.
  • 232 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2025.

Based on Mercer Global Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.